Monro's consultant-led turnaround, activist stakes, poison pill, and CEO equity vesting around $40 create incentives for a sale or value unlock.
MNRO — LONG Monro's consultant-led turnaround has attracted Icahn (17%) and Gabelli (6%), and their aggressive buys triggered a poison pill. The interim fixer is now permanent CEO with equity vesting at roughly $40 per share, aligning incentives toward a sale or value unlock.
Consultant-led turnaround draws Icahn 17% & Gabelli 6%, aggressive buys trigger poison pill. Interim fixer now perm CEO w/hefty equity vesting at ~$40/share. Incentives point to sale/unlock.
This Reddit post, published January 02, 2026, features u/ShowMeTheIncentives discussing MNRO. 1 trade idea extracted by AI with direction and confidence scoring.
Speakers: u/ShowMeTheIncentives · Tickers: MNRO